Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT00764517
Brief Title: Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma

First Submitted : October 1, 2008
First Submitted that Met QC Criteria : October 1, 2008
First Posted : October 2, 2008 (Estimate)

Results First Submitted : August 31, 2017
Results First Submitted that Met QC Criteria : October 11, 2017
Results First Posted : November 13, 2017

Certification/Extension First Submitted : November 28, 2016
Certification/Extension First Submitted that Met QC Criteria : November 28, 2016
Certification/Extension First Posted : December 29, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 9, 2017
Last Update Posted : December 11, 2017